Salmonella vaccine carrier strains: Effective delivery system to trigger anti-tumor immunity by oral route

European Journal of Immunology

Volumn 29, Issue 2, 1999, Pages 693-699

  Medina, Eva ^a   Guzmán, Carlos A ^a   Staendner, Lothar H ^a   Colombo, Mario P ^b   Paglia, Paola ^b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Anti tumor immunity; Live carrier; Oral vaccine; Salmonella typhimurium

Indexed keywords

BETA GALACTOSIDASE; LIVE VACCINE; SALMONELLOSIS VACCINE; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; FEMALE; FIBROSARCOMA; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; TUMOR IMMUNITY;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CYTOTOXICITY, IMMUNOLOGIC; DRUG CARRIERS; MICE; SALMONELLA;

EID: 0032992529     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199902)29:02<693::AID-IMMU693>3.0.CO;2-V     Document Type: Article

References (40)

1. Finlay, B. B. and Falkow, S., Salmonella as an intracellular parasite. Mol. Microbiol. 1989. 3: 1833-1841.
2. Dougan, G., Hormaeche, C. E. and Maskell, D. J., Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system. Parasite Immunol. 1987. 9: 151-160.
3. Jones, B. D., Ghori, N. and Falkow, S., Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J. Exp. Med. 1994.180: 15-23.
4. Brown, A., Hormaeche, C. E., Demarco de Hormaeche, R., Winther, M., Dougan, G., Maskell, D. J. and Stocker, B. A., An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice. J. Infect. Dis. 1987. 155: 86-92.
5. Buchmeier, N. A. and Heffron, F., Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium. Infect. Immun. 1991. 59: 2232-2238.
6. Harding, C. V. and Unanue, E. R., Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules. Cell Regul. 1990. 1: 499-509.
7. Pope, M., Kotlarski, I. and Doherty, K., Induction of Lyt-2-+ cytotoxic T lymphocytes following primary and secondary Salmonella infection. Immunology 1994. 81: 177-182.
8. Flynn, J. L., Weiss, W. R., Norris, K. A., Seifert, H. S., Kumar, S. and So, M., Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system. Mol. Microbiol. 1990. 4: 2111-2118.
9. Turner, S. J., Carbone, F. R. and Strugnell, R. A., Salmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infect. Immun. 1993. 61: 5374-5380.
10. Kovacsovics Bankowski, M., Clark, K., Benacerraf, B. and Rock, K. L., Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 1993. 90: 4942-4946.
11. Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J. and Harding, C. V., Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993. 361: 359-362.
12. Moore, M. W., Carbone, F. R. and Bevan, M. J., Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988. 54: 777-785.
13. Purner, M. B., Berens, R. L., Nash, P. B., van-Linden, A., Ross, E., Kruse, C., Krug, E. C. and Curiel, T. J., CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans. Infect. Immun. 1996. 64: 4330-4338.
14. Tan, J. S., Canaday, D. H., Boom, W. H., Balaji, K. N., Schwander, S. K. and Rich, E. A., Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J. Immunol. 1997. 159: 290-297.
15. Melief, C. J., Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res. 1992. 58: 143-175.
16. Boon, T., Cerottini, J. C., Van den Eynde, B., van der Bruggen, P. and Van Pel, A., Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 1994.12: 337-365.
17. Tite, J. P., Gao, X. M., Hughes Jenkins, C. M., Lipscombe, M., O'Callaghan, D., Dougan, G. and Liew, F. Y., Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier. Immunology 1990. 70: 540-546.
18. Nardelli Haefliger, D., Roden, R. B., Benyacoub, J., Sahli, R., Kraehenbuhl, J. P., Schiller, J. T., Lachat, P., Potts, A. and De Grandi, P., Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect. Immun. 1997. 65: 3328-3336.
19. Schodel, F., Milich, D. R. and Will, H., Hepatitis B virus nucleocapsid/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination. J. Immunol. 1990. 145: 4317-4321.
20. Darji, A., Guzmán, C. A., Gerstel, B., Wachholz, P., Timmis, K. N., Wehland, J., Chakraborty, T. and Weiss, S., Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 1997. 91: 765-775.
21. Paglia, P., Medina, E., Arioli, I., Guzmán, C. A. and Colombo, M. P., Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against murine fibrosarcoma. Blood 1998. 10: 46-56.
22. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar Costesec, A. and Boon, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 1992. 176: 1453-1457.
23. Holtel, A., Timmis, K. N. and Ramos, J. L., Upstream binding sequences of the XyIR activator protein and integration host factor in the xyIS gene promoter region of the Pseudomonas TOL plasmid. Nucleic Acids Res. 1992. 20: 1755-1762.
24. Lynch, S. A. and Houghton, A. N., Cancer Immunology. Curr. Opin. Oncol. 1993. 5: 145-150.
25. Vallera, D. A., Taylor, P. A., Aukerman, S. L. and Blazar, B. R., Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophagecolony stimulating factor and interleukin-2. Cancer Res. 1993. 53: 4273-4280.
26. Grooten, J. and Fiers, W., Acquisition by the murine host of responsiveness toward various neoplastic cell lines, but not toward self, through adoptive transfer of a helper T-lymphocyte clone with antiself specificity. Cancer Res. 1989. 49: 3872-3878.
27. Zhou, F., Rouse, B. T. and Huang, L., Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study. Cancer Res. 1992. 52: 6287-6291.
28. Jurcic, J. G., Scheinberg, D. A. and Houghton, A. N., Monoclonal antibody therapy of cancer. In Pineda, A., Longo, D. and Charner, B. (Eds.) Cancer Chemotherapy and Biological Modifiers. Elsevier, Amsterdam 1995, pp 234.
29. Manson, L. A., Anti-tumor immune responses of the tumor-bearing host: the case for antibody-mediated immunologic enhancement. Clin, Immunol. Immunopathol. 1994. 72: 1-8.
30. Pan, Z. K., Lazenby, A., Pardoll, D. and Paterson, Y., A recombinant Listeria monocytogenes vaccine expressing a model tumor antigen protects mice against lethal tumor challenge and causes regression of established tumors. Nature Med. 1995. 1: 471-477.
31. Paglia, P., Arioli, I., Frahm, N., Chakraborty, T., Colombo, M. P. and Guzmán, C. A., The defined attenuated Listeria monocytogenes Δmpl2 mutant is an effective oral vaccine carrier to trigger long lasting immune response against a mouse fibrosarcoma. Eur. J. Immunol. 1997. 27: 1570-1575.
32. Kaufmann, S. H. E., Immunity to intracellular bacteria. Rev. Immunol. 1993. 11: 129-163.
33. Havas, H. F., Axelrod, R. S., Burns, M. M., Murasko, D. and Goonewardene, M., Clinical results and immunologic efects of a mixed bacterial vaccine in cancer patients. Med. Oncol. Tumor Pharmacother. 1993. 10: 145-158.
34. Pawelek, J. M., Low, K. B. and Bermudas, D., Tumortargeted Salmonella as a novel anticancer vector. Cancer Res. 1997. 57: 4537-4544.
35. Hoiseth, S. K. and Stocker, B. A. D., Aromaticdependent Salmonella typhimurium are nonvirulent and effective as live vaccines. Nature 1981. 291: 238-239.
36. Paglia, P., Chiodoni, C., Rodolfo, M. and Colombo, M. P., Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 1996. 183: 317-322.
37. Rammensee, H. G., Schild, H. and Theopold, U., Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of beta-galactosidase. Immunogenetics 1989. 30: 296-302.
38. Sambrook, J., Fritsch, E. F. and Maniatis, T. (Eds.) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 1989.
39. O'Callaghan, D. and Charbit, A., High efficiency transformation of Salmonella typhimurium and Salmonella typhi by electroporation. Mol. Gen. Genet. 1990. 223: 156-158.
40. Matzinger, P., The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 1991.145:185-192.